These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

687 related items for PubMed ID: 12167476

  • 1. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells.
    Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV, Limtrakul PN.
    Biochem Pharmacol; 2002 Aug 15; 64(4):573-82. PubMed ID: 12167476
    [Abstract] [Full Text] [Related]

  • 2. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder.
    Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar SV, Limtrakul P.
    Biochem Pharmacol; 2004 Nov 15; 68(10):2043-52. PubMed ID: 15476675
    [Abstract] [Full Text] [Related]

  • 3. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV.
    Mol Cell Biochem; 2007 Feb 15; 296(1-2):85-95. PubMed ID: 16960658
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).
    Robey RW, Shukla S, Finley EM, Oldham RK, Barnett D, Ambudkar SV, Fojo T, Bates SE.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1302-12. PubMed ID: 18234154
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M, Ambudkar SV, Gottesman MM, Pastan I, Hrycyna CA.
    Mol Biol Cell; 1996 Oct 15; 7(10):1485-98. PubMed ID: 8898356
    [Abstract] [Full Text] [Related]

  • 9. Biochemical mechanism of modulation of human P-glycoprotein by stemofoline.
    Chanmahasathien W, Ohnuma S, Ambudkar SV, Limtrakul P.
    Planta Med; 2011 Dec 15; 77(18):1990-5. PubMed ID: 21786221
    [Abstract] [Full Text] [Related]

  • 10. P-glycoprotein efflux pump expression and activity in Calu-3 cells.
    Hamilton KO, Backstrom G, Yazdanian MA, Audus KL.
    J Pharm Sci; 2001 May 15; 90(5):647-58. PubMed ID: 11288109
    [Abstract] [Full Text] [Related]

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3).
    Kim SW, Kwon HY, Chi DW, Shim JH, Park JD, Lee YH, Pyo S, Rhee DK.
    Biochem Pharmacol; 2003 Jan 01; 65(1):75-82. PubMed ID: 12473381
    [Abstract] [Full Text] [Related]

  • 12. Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes.
    Romiti N, Tongiani R, Cervelli F, Chieli E.
    Life Sci; 1998 Jan 01; 62(25):2349-58. PubMed ID: 9651124
    [Abstract] [Full Text] [Related]

  • 13. A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes.
    Twentyman PR, Rhodes T, Rayner S.
    Eur J Cancer; 1994 Jan 01; 30A(9):1360-9. PubMed ID: 7999426
    [Abstract] [Full Text] [Related]

  • 14. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL, Winter MA, Hsaio SC, Pearce HL, Beck WT, Dantzig AH.
    Biochem Pharmacol; 1998 Sep 15; 56(6):719-27. PubMed ID: 9751076
    [Abstract] [Full Text] [Related]

  • 15. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
    Koizumi S, Konishi M, Ichihara T, Wada H, Matsukawa H, Goi K, Mizutani S.
    Eur J Cancer; 1995 Sep 15; 31A(10):1682-8. PubMed ID: 7488425
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
    Limtrakul P, Khantamat O, Pintha K.
    Cancer Chemother Pharmacol; 2004 Dec 15; 54(6):525-30. PubMed ID: 15248030
    [Abstract] [Full Text] [Related]

  • 17. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells.
    Wan CK, Zhu GY, Shen XL, Chattopadhyay A, Dey S, Fong WF.
    Biochem Pharmacol; 2006 Sep 28; 72(7):824-37. PubMed ID: 16889754
    [Abstract] [Full Text] [Related]

  • 18. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures.
    Hirsch-Ernst KI, Ziemann C, Rustenbeck I, Kahl GF.
    Toxicology; 2001 Oct 05; 167(1):47-57. PubMed ID: 11557129
    [Abstract] [Full Text] [Related]

  • 19. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein.
    Dey S, Ramachandra M, Pastan I, Gottesman MM, Ambudkar SV.
    Proc Natl Acad Sci U S A; 1997 Sep 30; 94(20):10594-9. PubMed ID: 9380680
    [Abstract] [Full Text] [Related]

  • 20. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids.
    Limtrakul P, Anuchapreeda S, Buddhasukh D.
    BMC Cancer; 2004 Apr 17; 4():13. PubMed ID: 15090070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.